Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in the lungs at the correct dosage.
Medtronic touts demand for PFA, adding to hype for the new ablation tech
By the numbers Q4 sales: $8.59 billion 0.5% increase year over year FY 2024 sales: $32.36 billion 3.6% increase year over year FY 2024 net